Vaccine Research Center

Results: 325



#Item
61Plant-Derived Biologics Seminar and Public Hearing on Plant-Derived Biologics

Plant-Derived Biologics Seminar and Public Hearing on Plant-Derived Biologics

Add to Reading List

Source URL: www.fda.gov

Language: English
62Science at CBER: Why, How, and What?  SLIDE 1 This presentation will discuss science and, in particular, the research programs at the Center for Biologics; why CBER thinks they are so integral to the regulatory mission;

Science at CBER: Why, How, and What? SLIDE 1 This presentation will discuss science and, in particular, the research programs at the Center for Biologics; why CBER thinks they are so integral to the regulatory mission;

Add to Reading List

Source URL: www.fda.gov

Language: English
63Transcript of FDA Press Conference on FDA’s Role in Meeting the Challenges of Maintaining an Adequate Supply of Influenza Vaccine

Transcript of FDA Press Conference on FDA’s Role in Meeting the Challenges of Maintaining an Adequate Supply of Influenza Vaccine

Add to Reading List

Source URL: www.fda.gov

Language: English
64980  W H O Te c h n i c a l

980 W H O Te c h n i c a l

Add to Reading List

Source URL: www.wsmi.org

Language: English - Date: 2014-07-04 08:25:09
65979  W H O Te c h n i c a l

979 W H O Te c h n i c a l

Add to Reading List

Source URL: www.wsmi.org

Language: English - Date: 2013-11-18 07:43:58
66DRAFT  August 14, 2014 ADVISORY COMMISSION ON CHILDHOOD VACCINES (ACCV) Parklawn Building, 5600 Fishers Lane, Rockville, Maryland

DRAFT August 14, 2014 ADVISORY COMMISSION ON CHILDHOOD VACCINES (ACCV) Parklawn Building, 5600 Fishers Lane, Rockville, Maryland

Add to Reading List

Source URL: www.hrsa.gov

Language: English - Date: 2014-12-09 01:13:12
67Center for Biologic Evaluation and Research List of Licensed Biological Products with (1) Reference Product Exclusivity and (2) Biosimilarity or Interchangeability Evaluations to Date

Center for Biologic Evaluation and Research List of Licensed Biological Products with (1) Reference Product Exclusivity and (2) Biosimilarity or Interchangeability Evaluations to Date

Add to Reading List

Source URL: www.fda.gov

Language: English
68Microsoft Word - VRC-CTC_Staff Clinician ad draft_cb_Julie_editsVersion 2_cb_ck-FINAL-8-14-Science

Microsoft Word - VRC-CTC_Staff Clinician ad draft_cb_Julie_editsVersion 2_cb_ck-FINAL-8-14-Science

Add to Reading List

Source URL: www.niaid.nih.gov

Language: English - Date: 2014-09-10 12:25:21
69Simian Virus 40: A Possible Human Polyomavirus Workshop

Simian Virus 40: A Possible Human Polyomavirus Workshop

Add to Reading List

Source URL: www.fda.gov

Language: English
70System Info[removed]SMITH, MICHAEL J 12-Feb[removed]:45:43 SMITHM RECORD OF TELEPHONE CONVERSATION Submission Type: Original Application Submission ID: [removed]Office: OVRR

System Info[removed]SMITH, MICHAEL J 12-Feb[removed]:45:43 SMITHM RECORD OF TELEPHONE CONVERSATION Submission Type: Original Application Submission ID: [removed]Office: OVRR

Add to Reading List

Source URL: www.fda.gov

Language: English